Schüssler-Fiorenza Rose, Sophia Miryam http://orcid.org/0000-0002-6311-6671
Contrepois, Kévin http://orcid.org/0000-0001-9678-5161
Moneghetti, Kegan J.
Zhou, Wenyu
Mishra, Tejaswini http://orcid.org/0000-0001-9931-1260
Mataraso, Samson http://orcid.org/0000-0003-3146-2243
Dagan-Rosenfeld, Orit
Ganz, Ariel B.
Dunn, Jessilyn
Hornburg, Daniel
Rego, Shannon
Perelman, Dalia
Ahadi, Sara
Sailani, M. Reza
Zhou, Yanjiao
Leopold, Shana R.
Chen, Jieming
Ashland, Melanie
Christle, Jeffrey W.
Avina, Monika
Limcaoco, Patricia
Ruiz, Camilo
Tan, Marilyn
Butte, Atul J. http://orcid.org/0000-0002-7433-2740
Weinstock, George M. http://orcid.org/0000-0002-2997-4592
Slavich, George M. http://orcid.org/0000-0001-5710-3818
Sodergren, Erica
McLaughlin, Tracey L.
Haddad, Francois http://orcid.org/0000-0002-9648-7671
Snyder, Michael P. http://orcid.org/0000-0003-0784-7987
Article History
Received: 10 May 2018
Accepted: 6 March 2019
First Online: 8 May 2019
Competing interests
: M.P.S. is a cofounder of Personalis, SensOmics, January, Filtricine, Qbio and Akna and an inventor on provisional patent number 62/814,746 ‘Methods for evaluation and treatment of glycemic dysregulation and applications thereof’. S.M.S.-F.R., K.C., W.Z., T.M. and S.M. are also listed as inventors. A.J.B. reports grants and non-financial support from Progenity, grants and personal fees from NIH (multiple institutes) and Genentech, and grants from L’Oreal, personal fees from NuMedii, Personalis, Lilly, Assay Depot, Geisinger Health, GNS Healthcare, uBiome, Roche, Wilson Sonsini Goodrich & Rosati, Orrick, Herrington & Sutcliffe, Verinata, 10x Genomics, Pathway Genomics, Guardant Health, Gerson Lehrman Group, Nuna Health, Samsung, Capital Royalty Group, Optum Labs, Pfizer, AbbVie, Bayer, Three Lakes Partners, HudsonAlpha, Tensegrity, Westat, FH Foundation, WuXi, FlareCapital, Helix, Roam Insights, Autodesk, Regenstrief Institute, American Medical Association, Precision Medicine World Conference, and Mars during the conduct of the study. A.J.B. has pending patent Atul J. Butte, Keiichi Kodama, Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus, published August 4, 2011, WO2011094731 and US20130071408; patent Joel T. Dudley, Atul J. Butte, Method and System for Computing and Integrating Genetic and Environmental Health Risks for a Personal Genome, published April 26, 2012, US20120101736 with royalties paid to Personalis; patent Joel T. Dudley, Atul J. Butte, Method And System For Functional Evolutionary Assessment Of Genetic Variants, published April 11, 2013, US20130090909 with royalties paid to Personalis; patent Konrad Karczewski, Michael Snyder, Atul J. Butte, Joel T. Dudley, Eurie Hong, Alan Boyle, J. Michael Cherry, Method and System for Assessment of Regulatory Variants in a Genome, published May 9, 2013, US20130116931 with royalties paid to Personalis; and patent Frederick Dewey, Euan Ashley, Carlos Daniel Bustamante, Atul Butte, Jake Byrnes, Rong Chen, Phased Whole Genome Genetic Risk In A Family Quartet, published March 28, 2013, US20130080068, with royalties paid to Personalis; Stanford University pays royalties each year on licensed intellectual property.